Suppr超能文献

COVID-19 患者中 D-二聚体与结局的相关性。

Correlation of D-dimer and Outcomes in COVID-19 Patients.

机构信息

Department of Trauma/Surgical Critical Care, The Medical Center Navicent Health and School of Medicine, 5225Mercer University, Macon, GA, USA.

School of Medicine, 5225Mercer University, Macon, GA, USA.

出版信息

Am Surg. 2022 Sep;88(9):2115-2118. doi: 10.1177/00031348221091940. Epub 2022 Apr 29.

Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) global pandemic has impacted daily life and medical practices around the world. Hospitals are continually making observations about this unique population as it relates to laboratory data and outcomes. Plasma D-dimer levels have been shown to be promising as a prognostic factor for outcomes in COVID-19 patients. This single institution retrospective study investigates the correlation between D-dimer and patient outcomes in our inpatient COVID-19 patient population.

METHODS

COVID-19 confirmed positive patients who were admitted between March 2020 and May 2020 at our hospital were identified. Admission and peak D-dimer values and patient outcomes, including intubation and mortality, were retrospectively analyzed.

RESULTS

Ninety-seven patients met criteria for inclusion in the study Mean age was 63.2 years, median admission D-dimer 2.35ug/mL, and median peak D-dimer 2.74ug/mL. Average time to peak D-dimer was 3.2 days. Patient's requiring intubation had higher admission D-dimers (3.79ug/mL vs. 1.62 ug/mL).

DISCUSSION

Higher admission and peak D-dimer values were associated with worsening clinical outcomes, specifically with higher rates of intubation and mortality. Noting D-dimer trends early in a patients' COVID course, regardless of patients' clinical condition, may allow opportunities for physicians to provide early intervention to prevent these outcomes.

摘要

背景

2019 年冠状病毒病(COVID-19)全球大流行影响了全世界的日常生活和医疗实践。医院不断观察这一独特人群与实验室数据和结果的关系。血浆 D-二聚体水平已被证明是 COVID-19 患者预后的一个有前途的预测因素。这项单中心回顾性研究调查了我们住院 COVID-19 患者人群中 D-二聚体与患者结局之间的相关性。

方法

确定了我们医院在 2020 年 3 月至 2020 年 5 月期间收治的 COVID-19 确诊阳性患者。回顾性分析了入院时和峰值 D-二聚体值以及患者结局,包括插管和死亡率。

结果

97 名患者符合纳入研究标准。平均年龄为 63.2 岁,中位入院 D-二聚体 2.35ug/mL,中位峰值 D-二聚体 2.74ug/mL。达到峰值 D-二聚体的平均时间为 3.2 天。需要插管的患者入院 D-二聚体值较高(3.79ug/mL 比 1.62ug/mL)。

讨论

较高的入院和峰值 D-二聚体值与临床结局恶化相关,特别是与插管和死亡率较高相关。无论患者的临床状况如何,在患者 COVID 病程早期注意 D-二聚体趋势,可能为医生提供早期干预机会,以预防这些结局。

相似文献

1
Correlation of D-dimer and Outcomes in COVID-19 Patients.COVID-19 患者中 D-二聚体与结局的相关性。
Am Surg. 2022 Sep;88(9):2115-2118. doi: 10.1177/00031348221091940. Epub 2022 Apr 29.
10
Elevated levels of D-dimer in patients with COVID-19: prognosis value.新型冠状病毒肺炎患者D-二聚体水平升高:预后价值
Pan Afr Med J. 2020 Jul 7;35(Suppl 2):105. doi: 10.11604/pamj.supp.2020.35.2.24692. eCollection 2020.

引用本文的文献

5
Pulmonary embolism in children with mycoplasma pneumonia: can it be predicted?支原体肺炎患儿的肺栓塞:能否预测?
Eur J Clin Microbiol Infect Dis. 2025 Feb;44(2):393-403. doi: 10.1007/s10096-024-05014-3. Epub 2024 Dec 17.

本文引用的文献

2
Novel insights on the pulmonary vascular consequences of COVID-19.新型冠状病毒肺炎对肺血管影响的新认识。
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L277-L288. doi: 10.1152/ajplung.00195.2020. Epub 2020 Jun 17.
10
A Test in Context: D-Dimer.在背景下的检测:D-二聚体。
J Am Coll Cardiol. 2017 Nov 7;70(19):2411-2420. doi: 10.1016/j.jacc.2017.09.024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验